Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp148 | Interdisciplinary Endocrinology 1 | ECE2019

Risk of myocardial infarction (MI), stroke, and other cardiovascular (CV) conditions in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study

Chen Kristina , Kaul Sanjiv , Curhan Gary , Gosmanova Elvira O. , Mu Fan , Swallow Elyse , Briggs Allison , Sherry Nicole , Ketteler Markus , Rejnmark Lars

Background: Prior small studies have suggested increased risk of cardiovascular (CV) conditions in patients with hypoparathyroidism (HypoPT). We evaluated whether chronic HypoPT is associated with increased risk of select CV hard endpoints (i.e., myocardial infarction (MI), stroke, and a composite CV endpoint) in a large contemporary cohort.Methods: A retrospective cohort study, based on a US commercial claims database (Q1 2007 - Q2 2017), was conducted ...

ea0049ep586 | Diabetes therapy | ECE2017

Effects of inositol on glucose homeostasis: systematic review and meta-analysis of randomized controlled trials

Minambres Inka , Cuixart Gemma , Goncalves Ana , Corcoy Rosa

Aim: To analyze the effects of inositol administration on parameters related to glucose homeostasis.Material and methods: Systematic review and meta-analysis of articles published in Medline or Web of Science Until February 1, 2016. We included studies that met the following criteria: i) Randomized controlled clinical trials of inositol/inositol isomer supplementation against placebo in parallel design, ii) performed in humans, iii) with information abou...

ea0037gp.14.07 | Diabetes and obesity – Clinical diabetes | ECE2015

Degree of control of type 2 diabetes in Spain according to individualised glycaemic targets

Minambres Inka , Mediavilla Jose Javier , Gonzalez-Segura Diego , Perez Antonio

Our objective was to estimate the distribution of Spanish diabetic patients attending to individualized glycaemic targets recommended by the ADA/EASD consensus with and without considering hypoglycaemia risk. We conducted a cross-sectional study in a Spanish primary care setting between 2011 and 2012. A total of 5382 type 2 diabetic subjects under antihyperglycaemic treatment for at least 3 months prior to inclusion completed a study visit in which clinical data including age,...

ea0011p295 | Diabetes, metabolism and cardiovascular | ECE2006

Metabolic syndrome and insulin sensitivity in early glycoregulation disorders

Vesna Dimitrijevic-Sreckovic VDS , Predrag Djordjevic PDJ , Srdjan Popovic SP , Drasko Gostiljac DG , Fadil Canovic FC , Branko Sreckovic BS , Miroljub Ilic MI , Tanja Novakovic TN , Emina Colak EC , Radmila Obrenovic RO , Gordana Milic GM , Tanja Nisic TN , Visnja Panasiuk VP

Background and Aims: Early glycoregulation disorders, impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) are associated with metabolic syndrome (MS). The aim of this study is: (a) to analyze parameters of insulin sensitivity, glycoregulation, lipid status, microalbuminuria (MI) and homocysteine (HCY) in patients with obesity (I), IFG (II), IGT (III) and newly diagnosed DM type 2 (IV) patients; (b) to determine the percentage of metabolic syndrome at these pati...

ea0032p1001 | Thyroid (non-cancer) | ECE2013

In pregnant women receiving levothyroxine, higher 3rd trimester TSH and maternal underweight are associated with cesarean section due to foetal malposition

Minambres Inka , Aulinas Anna , Claramonte Marta , Martinez Sonia , Garcia-Patterson Apolonia , Maria Adelantado Juan , Corcoy Rosa

Context: In the background population, maternal TSH levels >2.5 mUI/l in late pregnancy have been reported to be associated with breech presentation. This has not been addressed in women treated with levothyroxine.Aim: Our aim was to study the relationship of 3rd trimester maternal TSH with caesarean section (CS) due to foetal malposition in pregnant women treated with levothyroxine since before pregnancy.Methods: We have studi...

ea0016p269 | Endocrine disruptors | ECE2008

The UV absorber 4-methylbenzylidene-camphor (4-MBC) causes effects comparable to primary hypothyroidism

Gotthardt Inka , Schmutzler Cornelia , Petra Kirschmeyer , Wolfgang Wuttke , Hubertus Jarry , Josef Kohrle

The endocrine active compound 4-methylbenzylidene-camphor (4-MBC) is frequently used as an UV absorber in sunscreens and various skin care products. Though 4-MBC is weakly estrogenic in the reproductive system of fishes and rodents it shows strong anti-osteoporotic effects. Furthermore, different studies show percutanous absorption of 4-MBC after dermal administration resulting in identical biotransformation in humans and rats. Female Sprague-Dawley rats received five concentr...

ea0092ps3-27-07 | Thyroid Cancer clinical 3 | ETA2023

Clinical significance of de novo appearance of anti-thyroglobulin antibodies in patients of differentiated thyroid cancer with radioiodine therapy

Shim Hyekyung , Ra Kim Mi

Objectives: This study analyzed the prevalence of newly discovered anti-thyroglobulin antibody (TgAb) and its clinical significance during the follow-up period of patients with differentiated thyroid cancer.Methods: Among patients who underwent total thyroidectomy and radioactive iodine treatment between 2008 and 2022 in a single center, 184 patients (23 male, 161 female) with Tg<1ng/ml and TgAb positive (> 60 IU/mL) at least once were targeted. ...

ea0056p533 | Obesity | ECE2018

Effectiveness of bariatric surgery in metabolically healthy obese patients

Tuneu Laura , Ramos Analia , Genua Idoia , Stantonyonge Nicole , Caimari Francisca , Balague Carmen , Fernandez-Ananin Sonia , Perez Antonio , Minambres Inka

Objective: To evaluate the effectiveness and security of bariatric surgery in metabolically healthy obese (MHO).Methods: A retrospective study of a cohort of all obese patients who underwent to bariatric surgery with a minimum two-year follow-up. Databases of all demographic, anthropometric and metabolic characteristics have been collected since 2007. Patients undergoing two surgeries were excluded. We defined as MHO patients those without diagnosis of d...

ea0081p70 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Cause of Death for Patients with Diabetes Mellitus in Korea: Multicenter study

Moon Hyeyeon , Park Mi Kyoung , Suh Sunghwan

Background: In Republic of Korea, prevalence of type 2 diabetes mellitus (T2DM) has increased substantially in recent decades, but there are no reliable estimates of the excess mortality currently associated with diabetes.Methods: We analyzed all subjects were T2DM patients over the age of 30 whose death certificates were issued at three hospitals in the Busan metropolitan area from 2010 to 2014. The causes of death were retrospectively determined based ...

ea0041ep433 | Diabetes (to include epidemiology, pathophysiology) | ECE2016

Cause-of-death trends for diabetes mellitus over 20 years

Suh Sunghwan , Kim Mi-Kyung , Park Mi-Kyoung , Kim Duk Kyu

Background: Recently, diabetic mortality is lower than ever before, likely due to dramatic improvements in diabetes care. This study set to analyze changes in the cause of death in type 2 diabetes mellitus (T2DM) in the past 20 years.Methods: All subjects were T2DM patients over the age of 30 whose death certificates were issued at six hospitals in the Busan metropolitan area from 2010 to 2014. The patients were excluded if they had been clinically diagn...